These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7596959)

  • 21. Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat.
    Cudennec A; Fage D; Bénavidès J; Scatton B
    Brain Res; 1997 Sep; 768(1-2):257-65. PubMed ID: 9369323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosulpiride associated neuroleptic malignant syndrome in an elderly patient: a tale of confusing brand names.
    Kaur U; Acharya K; Singh A; Gambhir IS; Chakrabarti SS
    Acta Neurol Belg; 2022 Aug; 122(4):1103-1105. PubMed ID: 33609249
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects.
    Cho HY; Yoo HD; Lee YB
    Neuroscience; 2010 Aug; 169(1):378-87. PubMed ID: 20438811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
    Usuda S; Nishikori K; Noshiro O; Maeno H
    Psychopharmacology (Berl); 1981; 73(2):103-9. PubMed ID: 6112770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
    Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levosulpiride. Levopraid, RV 12309.
    Drugs R D; 1999 Oct; 2(4):247-8. PubMed ID: 10659401
    [No Abstract]   [Full Text] [Related]  

  • 28. Improvement of vestibular compensation by Levo-sulpiride in acute unilateral labyrinthine dysfunction.
    Zanetti D; Civiero N; Balzanelli C; Tonini M; Antonelli AR
    Acta Otorhinolaryngol Ital; 2004 Apr; 24(2):49-57. PubMed ID: 15468991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol.
    de Bartolomeis A; Marmo F; Buonaguro EF; Rossi R; Tomasetti C; Iasevoli F
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1516-29. PubMed ID: 23357084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?
    Baptista T; Parada M; Hernandez L
    Pharmacol Biochem Behav; 1987 Jul; 27(3):399-405. PubMed ID: 2889218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-supraoptic nucleus sulpiride improves anorexia in tumor-bearing rats.
    Sato T; Fetissov SO; Meguid MM; Miyata G; Chen C
    Neuroreport; 2001 Aug; 12(11):2429-32. PubMed ID: 11496123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons.
    Watanabe K; Kimura M
    J Neurophysiol; 1998 May; 79(5):2568-80. PubMed ID: 9582229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of D2-dopamine receptor antagonist levosulpiride on diabetic cholecystoparesis: a double-blind crossover study.
    Mansi C; Savarino V; Vigneri S; Sciabà L; Perilli D; Mele MR; Celle G
    Aliment Pharmacol Ther; 1995 Apr; 9(2):185-9. PubMed ID: 7605860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
    Obuchowicz E
    Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.
    Alander T; Andén NE; Grabowska-Andén M
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):145-50. PubMed ID: 7402361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of dopamine research in schizophrenia.
    Pani L
    Curr Med Res Opin; 2002; 18 Suppl 3():s3-7. PubMed ID: 12418605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR; Tabatabai SA
    Psychopharmacology (Berl); 1992; 107(2-3):341-6. PubMed ID: 1535446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.